Surviving the cure

See allHide authors and affiliations

Science  14 Jul 2017:
Vol. 357, Issue 6347, pp. 122-125
DOI: 10.1126/science.357.6347.122

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed.  Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Enter the characters shown in the image.

Vertical Tabs

  • RE: Leukaemia article

    May I suggest that the patient visit professional herbalist such as myself who has specialised in cancers. Much of the side effects might have been avoided. More importantly the concept of repopulating stem cells into the existing bone marrow or terrain will never ultimately work. The existing terrain is compromised and rotten hence the disease. You have to change the terrain or landscape to enable a cure or recovery. Unfortunately much of the east coast of the US is still in denial of the positive effects of plant medicine.

    Competing Interests: None declared.
  • RE: Surviving the disease
    • Silvio Pitlik, Physician, Visiting Scientist, Weizmann Institute of Science
    • Other Contributors:
      • Nina Pitlik, Pharmacologist, The Academic College of Tel Aviv-Yaffo

    Despite all of our understanding of mechanisms of disease, this case dramatically exemplifies that the optimal scenario is recovering naturally or spontaneously from a not diagnosed disease.

    Competing Interests: None declared.